使用可解释的人工智能和代谢学来识别新的高血压生物标志物
Karthik Sekaran1, Hatem Zayed2
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Metabolomics : Official journal of the Metabolomic Society
|November 3, 2024
概括
这项研究确定了新的代谢物生物标志物,包括瓦尼曼酸 (VMA),用于卡塔尔的高血压诊断. 可解释的人工智能 (XAI) 增强了对这种日益严重的公共卫生问题的早期检测和治疗策略.
科学领域:
- 代谢学 代谢学 代谢学
- 生物标志物发现发现
- 医疗保健中的人工智能
背景情况:
- 高血压是一个全球性健康问题,影响到33%的成年人,代谢功能障碍是主要的驱动因素.
- 早期检测和干预对于预防与高血压相关的严重健康并发症至关重要.
- 识别可靠的生物标志物可以改善高血压的诊断和治疗策略.
研究的目的:
- 利用可解释的人工智能 (XAI) 来解释与高血压相关的新型代谢物生物签名.
- 确定在卡塔尔人口中高血压的特定代谢标志物.
- 通过先进的AI分析,增强对高血压中代谢功能障碍的理解.
主要方法:
- 液体染色学-质谱学 (LC/MS) 用于在卡塔尔高血压患者和对照人群中分析代谢物.
- 使用Metabolon平台进行代谢物注释,然后进行数据预处理和特征选择.
- 可解释性AI (XAI) 模型,包括光梯度增强和SHAP,用于生物标志物的发现和解释.
主要成果:
- 增高的瓦尼曼代利酸 (VMA) 水平与第一阶段高血压有显著的关联.
- 甘油醇胆 (GPC),N-Stearoylsphingosine和甘氨酸被确定为高血压预测的关键代谢物.
- 光梯度增强模型实现了通过SHAP分析验证的高分类指标 (准确率78.13%,AUROC 83.88%).
结论:
- 新的代谢物生物标志物被确定用于在卡塔尔人口中精确诊断高血压.
- XAI有效地阐明了代谢物标记,加深了对高血压病理学的理解.
- 这些发现支持加强对高血压的早期检测和干预策略.
更多相关视频
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
465
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.2K
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
01:25Errors occurring during blood pressure monitoring
605
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
605
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61